P. Robinan Gentry

2.4k total citations
65 papers, 1.8k citations indexed

About

P. Robinan Gentry is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research and Environmental Chemistry. According to data from OpenAlex, P. Robinan Gentry has authored 65 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Health, Toxicology and Mutagenesis, 34 papers in Cancer Research and 14 papers in Environmental Chemistry. Recurrent topics in P. Robinan Gentry's work include Carcinogens and Genotoxicity Assessment (34 papers), Effects and risks of endocrine disrupting chemicals (16 papers) and Heavy Metal Exposure and Toxicity (14 papers). P. Robinan Gentry is often cited by papers focused on Carcinogens and Genotoxicity Assessment (34 papers), Effects and risks of endocrine disrupting chemicals (16 papers) and Heavy Metal Exposure and Toxicity (14 papers). P. Robinan Gentry collaborates with scholars based in United States, Canada and Australia. P. Robinan Gentry's co-authors include Harvey J. Clewell, Tammie R. Covington, Melvin E. Andersen, Jeffrey Gearhart, Annette M. Shipp, Janice W. Yager, R. Sarangapani, Justin Teeguarden, Kenny S. Crump and Cynthia Van Landingham and has published in prestigious journals such as The Science of The Total Environment, Environmental Health Perspectives and Chemosphere.

In The Last Decade

P. Robinan Gentry

63 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P. Robinan Gentry United States 26 1.0k 577 356 239 211 65 1.8k
Yu‐Mei Tan United States 25 1.4k 1.4× 469 0.8× 511 1.4× 133 0.6× 209 1.0× 57 2.2k
Moiz Mumtaz United States 28 1.3k 1.2× 442 0.8× 167 0.5× 146 0.6× 279 1.3× 92 2.2k
Sami Haddad Canada 35 1.2k 1.2× 451 0.8× 153 0.4× 536 2.2× 327 1.5× 117 3.0k
Miyoung Yoon United States 20 797 0.8× 186 0.3× 312 0.9× 134 0.6× 128 0.6× 69 1.5k
Chad M. Thompson United States 33 1.4k 1.3× 359 0.6× 188 0.5× 205 0.9× 462 2.2× 98 2.7k
Hisham El‐Masri United States 24 597 0.6× 287 0.5× 146 0.4× 116 0.5× 226 1.1× 56 1.2k
Bruce C. Allen United States 28 846 0.8× 716 1.2× 140 0.4× 137 0.6× 519 2.5× 70 2.4k
John C. Lipscomb United States 26 1.1k 1.1× 611 1.1× 167 0.5× 662 2.8× 355 1.7× 69 2.6k
Lisa Sweeney United States 20 559 0.5× 376 0.7× 217 0.6× 126 0.5× 218 1.0× 74 1.5k
Christopher R. Kirman United States 26 984 1.0× 445 0.8× 162 0.5× 68 0.3× 176 0.8× 84 1.8k

Countries citing papers authored by P. Robinan Gentry

Since Specialization
Citations

This map shows the geographic impact of P. Robinan Gentry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Robinan Gentry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Robinan Gentry more than expected).

Fields of papers citing papers by P. Robinan Gentry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Robinan Gentry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Robinan Gentry. The network helps show where P. Robinan Gentry may publish in the future.

Co-authorship network of co-authors of P. Robinan Gentry

This figure shows the co-authorship network connecting the top 25 collaborators of P. Robinan Gentry. A scholar is included among the top collaborators of P. Robinan Gentry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Robinan Gentry. P. Robinan Gentry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Conolly, Rory B., Jeffry D. Schroeter, Julia S. Kimbell, et al.. (2023). Updating the biologically based dose-response model for the nasal carcinogenicity of inhaled formaldehyde in the F344 rat. Toxicological Sciences. 193(1). 1–17. 1 indexed citations
3.
Campbell, Jerry L., Harvey J. Clewell, Cynthia Van Landingham, P. Robinan Gentry, & Melvin E. Andersen. (2023). Using available in vitro metabolite identification and time course kinetics for β-chloroprene and its metabolite, (1-chloroethenyl) oxirane, to include reactive oxidative metabolites and glutathione depletion in a PBPK model for β-chloroprene. Frontiers in Pharmacology. 14. 1223808–1223808.
4.
Yoon, Miyoung, Alina Efremenko, Cynthia Van Landingham, et al.. (2019). Updating physiologically based pharmacokinetic models for manganese by incorporating rapid association/dissociation processes in tissues. Toxicology and Applied Pharmacology. 372. 1–10. 2 indexed citations
5.
Clewell, Harvey J., Jerry L. Campbell, Cynthia Van Landingham, et al.. (2019). Incorporation of in vitro metabolism data and physiologically based pharmacokinetic modeling in a risk assessment for chloroprene. Inhalation Toxicology. 31(13-14). 468–483. 12 indexed citations
6.
Andersen, Melvin E., P. Robinan Gentry, James A. Swenberg, et al.. (2019). Considerations for refining the risk assessment process for formaldehyde: Results from an interdisciplinary workshop. Regulatory Toxicology and Pharmacology. 106. 210–223. 17 indexed citations
7.
Song, Gina, Cynthia Van Landingham, P. Robinan Gentry, et al.. (2018). Physiologically-based pharmacokinetic modeling suggests similar bioavailability of Mn from diet and drinking water. Toxicology and Applied Pharmacology. 359. 70–81. 2 indexed citations
8.
Gentry, P. Robinan, Janice W. Yager, Rebecca A. Clewell, & Harvey J. Clewell. (2014). Use of mode of action data to inform a dose–response assessment for bladder cancer following exposure to inorganic arsenic. Toxicology in Vitro. 28(7). 1196–1205. 11 indexed citations
9.
Gentry, P. Robinan, et al.. (2014). The impact of recent advances in research on arsenic cancer risk assessment. Regulatory Toxicology and Pharmacology. 69(1). 91–104. 30 indexed citations
10.
Gentry, P. Robinan, Joseph V. Rodricks, Duncan Turnbull, et al.. (2013). Formaldehyde exposure and leukemia: Critical review and reevaluation of the results from a study that is the focus for evidence of biological plausibility. Critical Reviews in Toxicology. 43(8). 661–670. 27 indexed citations
11.
Gentry, P. Robinan, et al.. (2013). Potential occupational risk of amines in carbon capture for power generation. International Archives of Occupational and Environmental Health. 87(6). 591–606. 18 indexed citations
12.
Gentry, P. Robinan, Harvey J. Clewell, Rebecca A. Clewell, et al.. (2011). Challenges in the application of quantitative approaches in risk assessment: a case study with di-(2-ethylhexyl)phthalate. Critical Reviews in Toxicology. 41(sup2). 1–72. 26 indexed citations
13.
David, Raymond M., et al.. (2006). Revised assessment of cancer risk to dichloromethane II. Application of probabilistic methods to cancer risk determinations. Regulatory Toxicology and Pharmacology. 45(1). 55–65. 36 indexed citations
14.
Clewell, Harvey J., P. Robinan Gentry, Janet E. Kester, & Melvin E. Andersen. (2005). Evaluation of Physiologically Based Pharmacokinetic Models in Risk Assessment: An Example with Perchloroethylene. Critical Reviews in Toxicology. 35(5). 413–433. 27 indexed citations
15.
Clewell, Harvey J., P. Robinan Gentry, Tammie R. Covington, R. Sarangapani, & Justin Teeguarden. (2004). Evaluation of the Potential Impact of Age- and Gender-Specific Pharmacokinetic Differences on Tissue Dosimetry 2Current address: Novartis Pharmaceuticals, East Hanover, NJ 07936.. Toxicological Sciences. 79(2). 381–393. 148 indexed citations
16.
Gentry, P. Robinan, Tammie R. Covington, Sabine Mann, et al.. (2004). Physiologically Based Pharmacokinetic Modeling of Arsenic in the Mouse. Journal of Toxicology and Environmental Health. 67(1). 43–71. 32 indexed citations
17.
Gentry, P. Robinan, et al.. (2003). Application of a Physiologically Based Pharmacokinetic Model for Reference Dose and Reference Concentration Estimation for Acetone. Journal of Toxicology and Environmental Health. 66(23). 2209–2225. 17 indexed citations
18.
Clewell, Harvey J., P. Robinan Gentry, Jeffrey Gearhart, Bruce C. Allen, & Melvin E. Andersen. (2001). Comparison of cancer risk estimates for vinyl chloride using animal and human data with a PBPK model. The Science of The Total Environment. 274(1-3). 37–66. 77 indexed citations
19.
Clewell, Harvey J., Jeffery M. Gearhart, P. Robinan Gentry, et al.. (1999). Evaluation of the uncertainty in an oral reference dose for methylmercury due to interindividual variability in pharmacokinetics.. Risk Analysis. 19(4). 547–558. 97 indexed citations
20.
Clewell, Harvey J., P. Robinan Gentry, Jeffrey Gearhart, Bianca Allen, & Melvin E. Andersen. (1995). Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: Examples with vinyl chloride and trichloroethylene. Chemosphere. 31(1). 2561–2578. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026